Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re:.. nothing to do with "trigger". Tell us what you ment otherwise.
22
Apr 26, 2010 10:28AM

Brian, I suspect where he's coming from is that IF the BoD saw something coming along the lines of an organized effort by a few to acquire shares for the primary purpose of unseating them from their positions, they could easily thwart the action by issuing some or all of the already-authorized shares (100M) - hence dilution. That's my best guess anyway. And IMO, he's right, assuming the BoD is as nasty as some suggest.

SGE

Share
New Message
Please login to post a reply